CASC2 acts as a tumor suppressor in various types of cancers [48] and its expression level is reduced in the serum of diabetic nephropathy patients [49], tissues in db/db diabetic mouse, and high glucose-treated human renal mesangial cells [50] and podocyte cells [49,50,51,52]. This evidence concerns the gene CASC2 and cancer.